Source comparison
CJC-1295 In Vitro Research: Cell Model Comparison
Before selecting a cell line, ask what aspect of CJC-1295 biology you're investigating. Receptor pharmacology, intracellular signalling kinetics, or secretory dynamics? Each model system answers a different question. GH3 cells (rat pituitary adenoma) High (2–3
This comparison does not assign a generated winner or score.
- Before selecting a cell line, ask what aspect of CJC-1295 biology you're investigating. Receptor pharmacology, intracellular signalling kinetics, or secretory dynamics? Each model system answers a different question.
- GH3 cells (rat pituitary adenoma)
- High (2–3× native)
- Moderate
- Rapid growth, easy maintenance, high transfection efficiency for reporter assays
- Co-expresses prolactin; receptor density inflates apparent potency
- Receptor binding studies, cAMP assays, high-throughput screening
- RC-4B/C cells (rat somatotroph)
- Very high (5× native)
- Low
- Stable GHRH-R expression without prolactin interference
- Poor GH secretion limits use in functional assays
- Receptor pharmacology, competitive binding assays
- Primary rat pituitary culture
- Native density
- Physiological
- Preserves somatostatin receptor co-expression; pulsatile GH release mirrors in vivo dynamics
- Short viability (7–10 days), donor variability, technically demanding
- Translational studies, pulsatility research, validating dose predictions for animal models
- HEK293 cells + GHRH-R transfection
- Variable (tunable via plasmid dose)
- None (no GH gene)
- Clean system for isolating receptor signalling without endogenous GH machinery
- Requires co-transfection of GH reporter or measurement of upstream signals only
- Mechanistic dissection of GHRH-R signalling pathways (cAMP, MAPK, calcium flux)